Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 63Carcinoma, Non-Small-Cell Lung 60Rectal Neoplasms 44Glioblastoma 42Stomach Neoplasms 37Esophageal Neoplasms 33Brain Neoplasms 33Squamous Cell Carcinoma of Head and Neck 31Colorectal Neoplasms 29Pancreatic Neoplasms 26Lung Neoplasms 24Neoplasms 23Glioma 23Astrocytoma 22Neoplasm Metastasis 21Head and Neck Neoplasms 19Sarcoma 18Gliosarcoma 15Esophageal Squamous Cell Carcinoma 15Central Nervous System Neoplasms 15Ovarian Neoplasms 14Oligodendroglioma 13Melanoma 13Colonic Neoplasms 12Carcinoma, Hepatocellular 12Adenocarcinoma Of Esophagus 12Urinary Bladder Neoplasms 11Prostatic Neoplasms 11Oropharyngeal Neoplasms 9Carcinoma, Ovarian Epithelial 9

Interventions

pembrolizumab 1exemestane 1Tamoxifen 1Surgical Procedures, Operative 1Leuprolide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Premenopausal Breast Cancer × Surgical Procedures, Operative × Clear all
NCT04997941 2024-04-23

MORE-T

Seoul National University Hospital

Phase 2 Active not recruiting
238 enrolled
Breast

Premenopausal Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡